H & R sees a downgrade to Slightly Negative on account of less fundamental stars
The independent financial analyst theScreener just lowered the general evaluation of H & R (DE), active in the Commodity Chemicals industry. As regards its fundamental valuation, the title now shows 1 out of 4 stars while market behaviour can be considered moderately risky. theScreener believes that the title remains under pressure due to the loss of a star(s) and downgrades its general evaluation to Slightly Negative. As of the analysis date February 11, 2022, the closing price was EUR 7.14 and its target price was estimated at EUR 6.12.H&R GmbH & Co KGaA is a Germany-based developer and manufacturer of crude oil-based chemical and pharmaceutical products and precision plastic components. It operates through three segments: Chemical-Pharmaceutical Raw Materials Refining (ChemPharm Refining), Chemical-Pharmaceutical Raw Materials Sales (ChemPharm Sales) and Plastics. The ChemPharm Refining segment comprises two refineries in Germany, which produce plasticizers, paraffins, white oils and base oils; the ChemPharm Sales segment includes production and distribution sites worldwide and its main products are label-free plasticizers for the tire industry, as well as paraffins for various applications, and the Plastics segment produces precision plastic parts and molding tools to manufacture precision plastic parts.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.